Transform Patient Outcomes With Health Technology
We design, validate, and deploy diagnostics platforms, wearable biosensors, and AI-health systems — from first prototype to connected care at clinical scale.
Our Core Capabilities
Full-spectrum health technology engineering to power every stage of the patient journey.
Diagnostics Platforms
Assay development and point-of-care readers validated for clinical use
Learn more about Diagnostics PlatformsWearable Biosensors
Continuous multi-parameter monitoring that survives daily life
Learn more about Wearable BiosensorsAI-Health Systems
Clinical decision models built, validated, and monitored in production
Learn more about AI-Health SystemsMicrofluidics
Lab-on-chip design engineered for manufacturability at volume
Learn more about MicrofluidicsConnected Patient Care
Remote monitoring and care pathways wired into the record
Learn more about Connected Patient CareClinical Data & Compliance
Interoperability, quality systems, and regulatory readiness
Learn more about Clinical Data & Compliance28 free tools · no login
Featured tools for MedTech teams
Pathway, SaMD, HIPAA, 14971, diagnostics math and UDI — educational first-pass helpers.
510(k), De Novo, PMA or 510(k)-exempt — a structured first pass from class, predicates and novelty.
Map significance of the information × healthcare situation to IMDRF SaMD categories I–IV.
Paste text and flag likely matches to the 18 HIPAA identifiers before a dataset leaves the building.
Score severity × probability, see RPN bands, and keep a short hazard log in the browser.
A simplified Rule 1–22 walk to Class I, IIa, IIb or III — confirm against Annex VIII.
Sensitivity, specificity, PPV, NPV, likelihood ratios from TP/FP/FN/TN.
Validate or compute GS1 check digits for GTIN-8, GTIN-12, GTIN-13 and GTIN-14.
Two-arm mean or proportion studies — n per arm from alpha, power and effect size.
Ready to Accelerate Your Health Innovation?
Book a free consultation with our clinical engineering team and see how fast a validated system can reach patients.
Trusted by Clinical Leaders
"NexaMedTech rebuilt our diagnostic pathway end to end. Median time-to-treatment dropped 41% within two quarters of go-live."
"They took our biosensor from a promising bench prototype to a validated, manufacturable device. Usable-data yield went from 62% to 91%."
"Their validation discipline is the reason our model is actually in clinical use. Subgroup analysis and silent prospective testing caught what we would have missed."